COZAAR Drug Patent Profile
✉ Email this page to a colleague
When do Cozaar patents expire, and what generic alternatives are available?
Cozaar is a drug marketed by Organon and is included in one NDA.
The generic ingredient in COZAAR is losartan potassium. There are thirty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cozaar
A generic version of COZAAR was approved as losartan potassium by ALEMBIC PHARMS LTD on October 6th, 2010.
Summary for COZAAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 187 |
Clinical Trials: | 77 |
Patent Applications: | 4,384 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for COZAAR |
What excipients (inactive ingredients) are in COZAAR? | COZAAR excipients list |
DailyMed Link: | COZAAR at DailyMed |
Recent Clinical Trials for COZAAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Actuate Therapeutics | Phase 2 |
Colin D. Weekes, M.D. | Phase 2 |
Lustgarten Foundation | Phase 2 |
Pharmacology for COZAAR
Drug Class | Angiotensin 2 Receptor Blocker |
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for COZAAR
US Patents and Regulatory Information for COZAAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-001 | Apr 14, 1995 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COZAAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-001 | Apr 14, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-003 | Oct 13, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon | COZAAR | losartan potassium | TABLET;ORAL | 020386-002 | Apr 14, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COZAAR
See the table below for patents covering COZAAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2060656 | ⤷ Try a Trial | |
Denmark | 174700 | ⤷ Try a Trial | |
Germany | 19675001 | ⤷ Try a Trial | |
Japan | H03501020 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 8906233 | ⤷ Try a Trial | |
Germany | 69025473 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for COZAAR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0253310 | SPC/GB95/010 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 2-N-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL) METHYL) -5-(HYDROXYMETHYL) IMIDAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT; REGISTERED: SE 12209 19940902; UK 0025/0324 19941215; UK 0025/0336 19941215 |
0733366 | SZ 25/1998 | Austria | ⤷ Try a Trial | PRODUCT NAME: LOSARTAN-KALIUM UND HYDROCHLOROTHIAZID |
0480717 | 98C0025 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
0733366 | SPC/GB98/031 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 2-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL) BIPHENYL-4-YL)-METHYL)-5-(HYDROXYMETHYL)IMIDAZOLE (LOSARTAN),OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT( LOSARTAN POTASSIUM) AND HYDROCHLOROTHIAZIDE,; REGISTERED: FR 338520.7 19950215; FR 558453.7 19950215; UK 00025/0338 19960412 |
0253310 | 96C0020 | Belgium | ⤷ Try a Trial | PRODUCT NAME: KALII LOSARTAN; NAT. REGISTRATION NO/DATE: 922 IS 169 F3 19960130; FIRST REGISTRATION: SE 12209 19940902 |
0733366 | 98C0030 | Belgium | ⤷ Try a Trial | PRODUCT NAME: KALII LOSARTAN, HYDROCHLOROTHIAZIDUM; NAT. REGISTRATION NO/DATE: 922 IS 174 F 3 19980223; FIRST REGISTRATION: FR 338 520.7 19950215 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |